Anti-cancer drug-mediated increase in mitochondrial mass limits the application of metabolic viability-based MTT assay in cytotoxicity screening

Baldwin EL, Osheroff N (2005) Etoposide, topoisomerase II and cancer. Curr Med Chemistry-Anti-Cancer Agents 5:363–372

Bezawork-Geleta A, Rohlena J, Dong L, Pacak K, Neuzil J (2017) Mitochondrial complex II: at the crossroads. Trends Biochem Sci 42:312–325

Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378

Dornfeld K, Bjork J, Folkert G, Skildum A, Wallace KB (2021) Mitochondrial activities play a pivotal role in regulating cell cycle in response to doxorubicin. Cell Cycle 20:1067–1079

Fu X, Wan S, Lyu YL, Liu LF, Qi H (2008) Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation. PLoS One 3:e2009

Garn H, Krause H, Enzmann V, Dröβler K (1994) An improved MTT assay using the electron-coupling agent menadione. J Immunol Methods 168:253–256

Gerlier D, Thomasset N (1986) Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 94:57–63

Han M, Li J, Tan Q, Sun Y, Wang Y (2010) Limitations of the use of MTT assay for screening in drug discovery. J Chin Pharmaceu Sci 19:195–200

Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203–210

Jin P, Jiang J, Zhou L, Huang Z, Nice EC, Huang C et al (2022) Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol 15:1–42

Kumari N, Das A, Bhatt AN (2020) Interleukin-6 confers radio-resistance by inducing akt-mediated glycolysis and reducing mitochondrial damage in cells. J Biochem 167:303–314

Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63

Peng L, Wang B, Ren P (2005) Reduction of MTT by flavonoids in the absence of cells. Colloids Surf B Biointerfaces 45:108–111

Rai Y, Pathak R, Kumari N, Sah DK, Pandey S, Kalra N et al (2018) Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition. Sci Rep 8:1–15

Rai Y, Kumari N, Singh S, Kalra N, Soni R, Bhatt AN (2021) Mild mitochondrial uncoupling protects from ionizing radiation induced cell death by attenuating oxidative stress and mitochondrial damage. Biochim et Biophys Acta (BBA)-Bioenergetics 1862:148325

Rivankar S (2014) An overview of doxorubicin formulations in cancer therapy. J Cancer Res Ther 10:853–858

Sah DK, Rai Y, Chauhan A, Kumari N, Chaturvedi MM, Bhatt AN (2021) Sphingosine kinase inhibitor, SKI-II confers protection against the ionizing radiation by maintaining redox homeostasis most likely through Nrf2 signaling. Life Sci 278:119543

Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH et al (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827–4833

Shen L, Sun B, Sheng J, Yu S, Li Y, Xu H et al (2018) PGC1α promotes cisplatin resistance in human ovarian carcinoma cells through upregulation of mitochondrial biogenesis. Int J Oncol 53:404–416

Ulukaya E, Ozdikicioglu F, Oral AY, Demirci M (2008) The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested. Toxicol in Vitro 22:232–239

Van Rensburg CE, Anderson R, Jooné G, Myer MS, O’sullivan JF (1997) Novel tetramethylpiperidine-substituted phenazines are potent inhibitors of P-glycoprotein activity in a multidrug resistant cancer cell line. Anticancer Drugs 8:708–713

Van Tonder A, Joubert AM, Cromarty AD (2015) Limitations of the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. BMC Res Notes 8:1–10

Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR (1991) Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 51:2515–2520